Your session is about to expire
← Back to Search
Flax Beverage for Memory Issues
Study Summary
This trial will study whether flax beverage can improve memory in people with memory deficit, and whether this is linked to PET scan and blood biomarker results.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have experienced sudden changes in your bowel movements for more than 2 weeks, unexplained bleeding from the rectum, or you have not been able to have a bowel movement even after using a laxative.You have taken medications called neuroleptics or narcotic painkillers within the last 4 weeks before screening.You have a serious neurological condition like Parkinson's disease, brain tumor, or multiple sclerosis.You have taken medications for Parkinson's disease, like Sinemet or amantadine, within the past two months.You have trouble swallowing food or liquids.You have not taken certain medications like beta-blockers, narcotics, methyldopa, or clonidine in the 4 weeks leading up to the screening.You have experienced hallucinations or have been diagnosed with schizophrenia in the past.You have taken strong medications called corticosteroids within the last 3 months.You have taken certain anti-seizure medications in the past 2 months.You have never taken any FDA-approved medications for Alzheimer's disease before.You have a history of alcohol or drug abuse, which was discovered during the evaluation process.You have taken long-acting medications for anxiety or sleep within the past 4 weeks.You have taken certain medications that can cause significant side effects on the nervous system or bladder within the past 4 weeks.You have stomach pain, feeling sick, throwing up, or a high body temperature.You have allergies to any of the ingredients in the test product or placebo.You are allergic to any of the ingredients in the product or you have lactose intolerance.
- Group 1: Placebo control beverage group
- Group 2: Experimental flax beverage group
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Which patients are suitable for participating in this medical research?
"This medical trial is seeking 60 elderly individuals with mild memory disturbances between the ages of sixty and eighty-four. The primary eligibility requirement is that participants must fall within this age range."
Is this research endeavor seeking out participants who are at least 20 years old?
"As established by the entry requirements of this clinical trial, the minimum age for patient participation is 60 years old while 84 constitutes an upper limit."
How many participants are currently being enrolled in this experiment?
"Affirmative. According to clinicaltrials.gov, this study is actively looking for enrollees since it was initially posted on October 9th 2020 and last updated June 29th 2022. The trial will require 60 people between 2 medical sites."
Are there any vacancies for this medical trial?
"As indicated on clinicaltrials.gov, this is an active trial which was posted on October 9th 2020 and recently updated on June 29 2022."
Share this study with friends
Copy Link
Messenger